4-Year-Old Girl Left Nonverbal After Rhabdomyolysis from Common Cold
A New Jersey child developed a rare condition after a mild illness, leading to severe health complications.
The Brief
- A 4-year-old girl developed rhabdomyolysis after a common cold, resulting in heart and kidney failure.
- Her parents transported her to a hospital during a severe winter storm after noticing concerning symptoms.
- She now requires full-time care and ongoing treatment, including dialysis and therapy.
A 4-year-old girl from New Jersey developed rhabdomyolysis following a mild illness, leading to severe health complications. Her father, Joe Modica, described how the condition left her unable to walk or speak, requiring full-time care.
The family reported that the child initially showed symptoms of a common cold, which progressed to heart and kidney failure. Joe Modica explained that he noticed his daughter’s lips were purple and she was not warming up, prompting an emergency hospital visit.
At the hospital, doctors discovered her heart was failing, and she was taken via ambulance to a facility in Philadelphia due to a lack of pediatric ECMO at the initial hospital. Upon arrival, she stopped breathing for 18 minutes and was placed on a ventilator and ECMO machine.
Rhabdomyolysis, a rare condition where muscles break down and release toxins into the bloodstream, led to multi-organ failure. The child was placed on 24-hour dialysis and required extensive treatment. Her heart eventually recovered, but she continued to need ventilator and dialysis support.
The family is raising awareness about rhabdomyolysis, having learned of a recent death of a marathon runner from the same condition. They are urging greater awareness among athletes, families, and medical professionals about the risks of over-exertion and post-viral complications.
More in Health
-
Experimental Heart Drug Fails to Reduce Cardiovascular Risk
Novartis halts development of pelacarsen after large study shows no benefit in reducing heart attack or stroke risk.
-
Cholesterol Drug Fails to Prevent Heart Attacks in Trial
Novartis' pelacarsen did not reduce heart attack or stroke risk in clinical trial.
-
Man's Health Crisis Resolved by Surgeon's Second Look
A father's mysterious illness led to a life-saving surgery after months of misdiagnosis.
-
GLP-1 Users Report Burning Skin Sensation
Patients on weight loss medications report a painful skin condition linked to dosage increases.